OR WAIT 15 SECS
© 2021 MJH Life Sciences™ and Applied Clinical Trials Online. All rights reserved.
Applied Clinical Trials
AbbVie Inc. and Allergan plc have announced that they have entered into a definitive transaction agreement under which AbbVie will acquire Allergan for approximately $63 billion. The combined company will consist of several franchises with focus across immunology, hematologic oncology, medical aesthetics, neuroscience, women's health, eye care, and virology.
Learn all about the acquisition, right here.
Related Content:
News